Derivatives of midecamycine

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 9, 536 17, A61K 3170

Patent

active

041419715

ABSTRACT:
Novel derivatives of midecamycine, of the formula: ##STR1## wherein X represents an oxygen atom or a sulphur atom, R.sub.1 represents a straight or branched alkyl group, an alkenyl group or an aryl group, R.sub.2 represents a hydrogen atom or a lower acyl group, the dotted lines represent the possible presence of double bonds, it being understood that the 2 double bonds at the 10,11 position on the one hand and the 12,13 position on the other either exist simultaneously or neither of them exists, which give by oral administration plasma rates which are higher than midecamycine and which lack its bitter taste, together with their process of preparation.

REFERENCES:
patent: 3040025 (1962-06-01), Murphy et al.
patent: 3661891 (1972-05-01), Sinkula
Inouye et al., J. of Antibiotics, Jul. 1971, vol. 24, pp. 460-471.
Journal of Antibiotics, vol. 24, Jul.-Dec., 1971, pp. 457 and 480 (Table 4).
Journal of Antibiotics, vol. 29, No. 5, May, 1976, Japan Antibiotics Res. Assoc., pp. 536-548.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Derivatives of midecamycine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives of midecamycine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of midecamycine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-722881

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.